155058-02-9

Basic information

• Product Name: 1,6-Naphthyridin-5(6H)-one,7,8-dihydro-(9CI)
• Synonyms: 1,6-Naphthyridin-5(6H)-one,7,8-dihydro-(9CI);7,8-dihydro-1,6-naphthyridin-5(6H)-one;N-methyl-1-(1-methylpiperidin-4-yl)-2-(pyrrolidin-1-yl)ethanamine;1,6-Naphthyridin-5(6H)-one, 7,8-dihydro-;7,8-Dihydro-6H-[1,6]naphthyridin-5-one
• CAS NO: 155058-02-9
• Molecular Formula: C₈H₈N₂O
• Molecular Weight: 148.164
• Product Categories: PYRIDINE
• Mol File: 155058-02-9.mol
• Article Data: 7

Chemical Properties

• Melting Point: 163-166 °C(Solv: ethyl acetate (141-78-6))
• Boiling Point: 413.9±34.0 °C(Predicted)
• Appearance: /
• Density: 1.214±0.06 g/cm3(Predicted)
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 13.28±0.20(Predicted)
• CAS DataBase Reference: 1,6-Naphthyridin-5(6H)-one,7,8-dihydro-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1,6-Naphthyridin-5(6H)-one,7,8-dihydro-(9CI)(155058-02-9)
• EPA Substance Registry System: 1,6-Naphthyridin-5(6H)-one,7,8-dihydro-(9CI)(155058-02-9)

Safety Data

• Hazardous Substances Data: 155058-02-9(Hazardous Substances Data)

Usage

General Description

1,6-Naphthyridin-5(6H)-one,7,8-dihydro-(9CI) is a chemical compound with the molecular formula C10H8N2O. It is a heterocyclic organic compound that belongs to the naphthyridine class of compounds. This chemical has a fused-ring structure with a naphthyridine core, and it is classified as a dihydro derivative, meaning it contains two hydrogen atoms on the molecule. It is used in organic synthesis and pharmaceutical research, and its properties and potential applications are of interest to chemists and researchers in the field.

Upstream product

• 379670-41-4 methyl 2-((trimethylsilyl)ethynyl)nicotinate 
• 379670-43-6 methyl 2-ethynylnicotinate 
• 103441-72-1 2-ethenyl-3-pyridinecarboxylic acid methyl ester 
• 38749-79-0 3-bromo-2-picoline 
• 116986-08-4 methyl 2-(bromomethyl)pyridine-3-carboxylate 
• 65719-09-7 methyl 2-methylnicotinate 
• 1452-94-4 ethyl 2-chloronicotinate 
• 2942-59-8 2-chloronicotinic acid 
• 40134-18-7 methyl 2-chloropyridine-3-carboxylate 

Downstream Products

• 1312751-81-7 C₁₈H₁₆N₂O 
• 1312751-82-8 C₁₇H₁₃ClN₂O 
• 1312751-83-9 C₁₇H₁₃ClN₂O 
• 1312751-84-0 C₁₇H₁₃ClN₂O 
• 1312751-85-1 C₁₈H₁₆N₂O₂ 
• 1312751-78-2 6-methyl-2-phenylethynyl-7,8-dihydro-6H-1,6-naphthyridin-5-one 
• 1312751-79-3 C₁₈H₁₆N₂O 
• 1312751-80-6 C₁₈H₁₆N₂O 
• 80957-68-2 5,6,7,8-tetrahydro-1,6-naphthyridine 
• 1036381-91-5 tert‐butyl 2‐oxo‐1,5,7,8‐tetrahydro‐1,6‐naphthyridine‐6(2H)‐carboxylate 
• 259809-44-4 7,8-dihydro-5H-[1,6]naphthyridine-6-carboxylic acid tert-butyl ester 

Relevant articles and documents

INDOLE COMPOUNDS AS ANDROGEN RECEPTOR MODULATORS

Provided herein are compounds of formula (V) that bind to BF3 of an androgen receptor (AR), which can modulate the AR for the treatment of Kennedy's disease.

PRMT5 INHIBITORS AND USES THEREOF

Described herein are compounds of Formula (A), pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof:wherein Y1 is of formula (?) or formula (y):Ring Y is a 5- to 6-membered heteroaryl ring; and V4, V5, Rx, x, y, and n are as defined herein. Compounds of the present invention are useful for inhibiting PRMT5 activity. Methods of using the compounds for treating PRMT5-mediated disorders are also described.

Efficacy switching SAR of mGluR5 allosteric modulators: Highly potent positive and negative modulators from one chemotype

A series of metabotropic glutamate 5 receptor (mGluR5) allosteric ligands with positive, negative or no modulatory efficacy is described. The ability of this series to yield both mGluR5 PAMs and NAMs with single-digit nanomolar potency is unusual, and the